Life Sciences

Revitalize Growth

Generate Differentiated, Above Market Growth

The life sciences industry is expected to grow 3-6% this year, with academia’s continued strength and pharma/biotech sectors showing signs of return. In fact, applied markets including PFAs, semiconductor and energy are already realizing growth. To remain competitive, commercial leaders must evolve their go-to-market strategies to deliver customer value and manage commercial costs.

At Alexander Group, we help clients transform their commercial organizations by aligning Product, Marketing, Sales, Operations and Finance to deliver results.

How We Help

  • Revenue growth strategy: Target the right opportunities with the right value by determining your market opportunity and phase of growth.
  • Revenue motions: Define optimal value messaging and organize sales strategy around use cases.
  • Modern marketing blueprint: Evaluate current and new markets, areas of opportunity and optimize marketing channels, mix and return.
  • Talent: Ensure the organization has the right skills and capabilities for more complex offerings and portfolios.
  • Sales compensation: Align sales compensation and quota programs to motivate and achieve more aggressive business goals.
  • Actionable research & benchmarks: Provide current and relevant data, trends and benchmarks to help guide sales, marketing and operational decisions.

Participate in Our Research

Briefing Offers

Upcoming Life Sciences Events

  • Life Sciences 2027 Sales Compensation Planning

    Webinar

    Align Incentives With Growth

    October 27, 2026 | 11:00 a.m. – 12:00 p.m. ET

    As life sciences organizations finalize their 2027 commercial plans, sales compensation must keep pace.

    Product launches, portfolio expansion, evolving coverage models and higher productivity expectations are changing how commercial teams are expected to grow. The challenge is translating those priorities into role-specific plans, credible quotas, clear measures and differentiated rewards without creating unnecessary complexity or cost.

    Join Alexander Group’s Life Sciences practice leaders for a practical session designed to help commercial, sales operations, compensation, finance and HR leaders pressure-test their 2027 sales compensation programs before implementation.

    Craig Ackerman and Sean Higgins will walk attendees through the critical checks for pressure-testing 2027 sales compensation plans before implementation, helping identify gaps and areas that may require further refinement.

    The discussion will empower you to:

    • Translate your 2027 growth strategy into plan design: Connect priorities such as product launches, new customer acquisition, portfolio expansion, strategic-account growth and evolving coverage models to the roles, measures and behaviors your plans reinforce.
    • Establish a clear compensation philosophy: Define the principles that guide eligibility, pay-for-performance, role alignment and plan decisions across the organization.
    • Align plans to life sciences selling models: Examine lifecycle-based incentives for biotech and pharma, portfolio and installed-base growth for analytical instruments, and bookings-versus-revenue decisions for CROs, CDMOs and pharma services organizations.
    • Set credible quotas and differentiate performance: Connect forecast quality, territory potential, quota allocation and pay curves to create achievable goals, meaningful upside and stronger performance differentiation.
    • Balance motivation with financial discipline: Evaluate pay mix, measures, accelerators and incentive expense while maintaining plan simplicity, market competitiveness and compensation cost-of-sales alignment.
    • Build the governance required for successful execution: Establish decision rights, analytics, communication and change-management practices that help leaders implement plans on time, monitor effectiveness and reinforce intended behaviors after launch.

    Register now to pressure-test your 2027 sales compensation plan and identify the changes needed to support growth, productivity and commercial execution.

    • Tuesday, October 27, 2026
      11:00 a.m. – 12:00 p.m. ET
  • Talent Development: Change Is Coming in FY27. Are Your People Ready?

    Webinar

    FY27 is bringing sweeping commercial, talent and AI-driven changes. The organizations that thrive will be the ones who get their people ready first.  

    Join talent development leaders at Alexander Group to uncover the changes reshaping launch planning, the hidden hurdles standing between you and a successful FY27 and a practical, battle-tested readiness framework to align your leaders, managers and sellers before the year kicks off. Walk away with best practices and the key actions your teams need to hit the ground running. 

    Why Attend? 

    Many organizations invest heavily in strategy while underestimating people readiness, which is required to execute any strategy successfully. This webinar will help you: 

    • Understand the commercial, talent and AI-driven trends shaping FY27 planning.  
    • Identify the critical talent, leadership and enablement actions needed to prepare your commercial teams for the next fiscal year.  
    • Learn how leading organizations successfully launch and adopt new priorities, strategies and processes.  
    • Assess practical actions to accelerate change adoption across leaders, managers and sellers.  
    • Reduce execution gaps that can undermine even the strongest commercial strategies. 
    • Tuesday, November 10, 2026
      2:00 p.m. – 3:00 p.m. ET
    • Virtual

Life Sciences Research & Benchmarks

Get access to the latest go-to-market research and benchmarks to help shape your commercial strategy.

Meet the team

Alexander Group Can Help

How can you build upon your existing strengths to create value and reinvigorate differentiated, above market growth?